Sanofi 1Q Profit Declined on Lower Sales; Backs 2021 View
April 28 2021 - 2:23AM
Dow Jones News
By Cecilia Butini
Sanofi SA said Wednesday that net profit and sales fell for the
first quarter of 2021.
The French pharmaceutical major posted net profit of 1.57
billion euros ($1.90 billion), down from EUR1.68 billion a year
earlier, on sales that fell to EUR8.59 billion from EUR8.97
billion.
Sales of key growth driver Dupixent grew 45.6% in the quarter
despite the adverse environment created by the coronavirus
pandemic, Sanofi said.
Business net income--a key profit metric that excludes some
items--came in at EUR2.02 billion, compared with EUR2.04 billion.
Business earnings per share were EUR1.61, a 5.2% increase from a
year earlier.
The company backed its outlook for 2021, saying that it expects
business earnings per share to grow by a high-single digit at
constant exchange rates, barring unforeseen events.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 28, 2021 02:08 ET (06:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (EU:SAN)
Historical Stock Chart
From Apr 2023 to Apr 2024
